NuVasive announces fourth-quarter, full-year 2022 results
Click Here to Manage Email Alerts
NuVasive Inc. has released its fourth-quarter and full-year 2022 financial results, according to a company press release.
The company reported increased net sales of 1.1% for the fourth quarter of 2022 compared with the prior year period and increased net sales of 5.5% for full-year 2022 compared with 2021. In the release, NuVasive noted net sales were negatively impacted by fluctuation in foreign currency.
“Looking back at 2022, I am proud of our team for delivering another year of above-market, net sales growth,” Chris Barry, CEO of NuVasive, said in the release. “Looking ahead, I couldn’t be more excited to join forces with Globus Medical to create a leading, global musculoskeletal technology company. Our complementary commercial organizations and product portfolios make a strong financial profile and value creation opportunity for shareholders, while furthering our ability to increase customer reach and change more patient lives,” Barry said.
Read more about
Click Here to Manage Email Alerts